Advertisement
UK markets closed
  • FTSE 100

    8,145.64
    -1.39 (-0.02%)
     
  • FTSE 250

    19,997.80
    -86.99 (-0.43%)
     
  • AIM

    761.30
    -2.03 (-0.27%)
     
  • GBP/EUR

    1.1709
    -0.0003 (-0.03%)
     
  • GBP/USD

    1.2520
    -0.0042 (-0.34%)
     
  • Bitcoin GBP

    50,119.69
    -539.11 (-1.06%)
     
  • CMC Crypto 200

    1,302.91
    -36.16 (-2.70%)
     
  • S&P 500

    5,082.86
    -33.31 (-0.65%)
     
  • DOW

    38,085.76
    -300.33 (-0.78%)
     
  • CRUDE OIL

    81.89
    -0.74 (-0.90%)
     
  • GOLD FUTURES

    2,310.10
    -47.60 (-2.02%)
     
  • NIKKEI 225

    38,405.66
    +470.90 (+1.24%)
     
  • HANG SENG

    17,763.03
    +16.12 (+0.09%)
     
  • DAX

    17,935.18
    -183.14 (-1.01%)
     
  • CAC 40

    7,979.61
    -85.54 (-1.06%)
     

Eli Lilly Pops After Weight-Loss Drug Succeeds In Highly Anticipated Sleep Apnea Test

Eli Lilly Pops After Weight-Loss Drug Succeeds In Highly Anticipated Sleep Apnea Test

Eli Lilly stock popped Wednesday after the company's weight-loss drug significantly reduced nighttime sleep apnea events.